| 15374944 |
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia
Marynen, P,
Griffin, JD,
Furet, P,
Gilliland, DG,
Fabbro, D,
Mentens, N,
Clark, JJ,
Cools, J
|
Cancer Res. |
2004 |
| 16868253 |
The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases
Gilkes, AF,
Mills, KI,
Austin, SJ,
Burnett, AK,
Knapper, S,
Walsh, V
|
Blood |
2006 |
| 18483393 |
Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor
Grundler, R,
Schnittger, S,
Haferlach, T,
Duyster, J,
Breitenbuecher, F,
Huber, C,
Brecht, A,
Markova, B,
Fischer, T,
Carius, B
|
Blood |
2009 |
| 18068628 |
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles
Griffin, JD,
Golub, TR,
Gilliland, DG,
Heinrich, MC,
Ebert, BL,
Stone, RM,
Jiang, J,
Schittenhelm, MM,
Berger, R,
Lee, BH,
Deininger, MW,
Teckie, S,
Döhner, K,
Loriaux, M,
Fröhling, S,
Bernard, OA,
Scholl, C,
Boggon, TJ,
Levine, RL,
Döhner, H,
Druker, BJ
|
Cancer Cell |
2007 |
| 23392356 |
The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib
Yu, C,
Albers, C,
Verbeek, M,
Duyster, J,
Leischner, H,
Illert, AL,
von Bubnoff, N,
Peschel, C
|
Leukemia |
2013 |
| 19318574 |
FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro
Duyster, J,
Sänger, J,
Aberg, E,
Engh, RA,
Peschel, C,
von Bubnoff, N
|
Cancer Res. |
2009 |
| 23969938 |
Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia
Mullighan, CG,
Baker, SD,
Rubnitz, JE,
Zimmerman, EI,
Orwick, S,
Inaba, H,
Neale, GA,
Zatechka, DS,
Buaboonnam, J,
Enemark, EJ,
Shurtleff, S,
Wang, YD,
Olsen, SR
|
Clin. Cancer Res. |
2013 |
| 16150941 |
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain
Heidel, F,
Serve, H,
Solem, FK,
Schiller, GJ,
Breitenbuecher, F,
Giles, F,
Nimer, S,
Wang, Y,
Feldman, E,
Kindler, T,
Stone, RM,
Thiede, MH,
Huber, C,
Brandts, C,
Lipka, DB,
Roesel, J,
Kasper, S,
Ehninger, G,
Cohen, PS,
Fischer, T
|
Blood |
2006 |
